Skip to content
Home/GPs/VATEL CAPITAL
DetailCard
VATEL CAPITAL

VATEL CAPITAL

Paris, France·Founded 2008··vatelcapital.fr

Vatel Capital, founded in 2008 and based in Paris, is an independent and entrepreneurial asset management company specializing in financing and supporting French growth SMEs, both listed and unlisted, as well as investing in tangible assets like forests, agricultural land, and renewable energy. It manages over €550 million in assets and offers various investment solutions including FCPI, FIP, and funds focused on private debt and small caps.

AUM
€550M
Funds
2
vintages 2018–2021
Portfolio
14
Exits
2

VATEL CAPITAL is a Paris growth equity firm with €550M AUM, 14 active companies and 2 exits.

Sector breakdown

16 companies
ClimateTech
3 · 19%
Pharma
2 · 13%
Energy
2 · 13%
TMT
2 · 13%
Healthcare
1 · 6%
Fintech
1 · 6%
E-commerce
1 · 6%
Consumer
1 · 6%

Key facts

HQParis, France
Founded2008

Recent exits

VATEL CAPITAL sold Zoomalia to Holding Nicole in 2025 after 6 years.

VATEL CAPITAL sold OHRE Pharma to Strategic Generics France in 2021 after 3 years.

Coverage notes

2 funds tracked, 16 portfolio companies (14 active · 2 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund VATEL CAPITAL has raised, with its portfolio companies. Hand-checked from public filings.

2 funds
Vatel Flexibleharvesting
Evergreen2021€80M12 assets

Unrealized

12 held
CompanyEntry
Bio Jag
Healthcare · France
2023
Crossject
Pharma · France
2025
Enogia
Energy · France
2025
Entech
ClimateTech · France
2025
Haffner Energy
ClimateTech · France
2025
Hoffmann Green Cement
ClimateTech · France
2025
Iznes
Fintech · France
2025
Largo
E-commerce · France
2025
Lexibook
Consumer · France
2024
Median Technologies
MedTech · France
2025
Mipise
Industrials · France
2022
Odyssee Technologies
Aerospace & Defence · France
2024
Vatel Capitalharvesting
Evergreen2018€50M2 assets2 exits

Unrealized

2 held
CompanyEntry
Agripower
Energy · France
2019
Fill Up Media
TMT · France
2017

Realized

2 exits
CompanyEntryExitTypeBuyerMOIC
OHRE Pharma
Pharma · France
20182021Trade SaleStrategic Generics France–
Zoomalia
TMT · France
20192025Trade SaleHolding Nicole–

About VATEL CAPITAL

Vatel Capital is an independent and entrepreneurial asset management company with €550 million of assets under management, founded in 2008 and headquartered in Paris. The firm specialises in financing and supporting French growth SMEs (both listed and unlisted) with a multi-stage approach across the French SME ecosystem.

Investment thesis

Vatel Capital targets French growth SMEs across listed and unlisted segments, deploying growth equity and selective buyout commitments with equity tickets typically ranging from €5 million to €25 million per transaction. Sector focus spans TMT and selectively other French SME verticals, with the platform's hybrid listed/unlisted mandate distinguishing Vatel from pure private equity peers. The entrepreneurial heritage enables operational partnership with founder-operator management teams.

Recent activity

Recent realised exits include ZOOMALIA (TMT, 2025), reflecting selective distribution activity across the French SME portfolio. The platform tracks 3 funds, 7 active portfolio companies and 2 realised exits across the multi-vintage programme.

Frequently asked questions

What investment strategy does VATEL CAPITAL focus on?
VATEL CAPITAL focuses on Growth, Buyout strategies in the private equity space.
How many portfolio companies does VATEL CAPITAL have?
VATEL CAPITAL has 14 active portfolio companies and 2 completed exits and 2 funds tracked on GP Intel.
Where is VATEL CAPITAL headquartered?
VATEL CAPITAL is headquartered in Paris, France.
What is VATEL CAPITAL's assets under management?
VATEL CAPITAL manages approximately €550M in assets under management.
When was VATEL CAPITAL founded?
VATEL CAPITAL was founded in 2008.
What sectors does VATEL CAPITAL invest in?
VATEL CAPITAL invests across Healthcare, Energy, Business Services, Industrials.
What are VATEL CAPITAL's recent exits?
Recent realized exits by VATEL CAPITAL include: ZOOMALIA (2025) to Holding Nicole; OHRE Pharma (2021) to Strategic Generics France.
Look up another firm or company
Last updated May 2026 · Sourced from public filings · Report an issue